FDA advisory committee recommends approval of a booster shot of the Johnson & Johnson COVID vaccine

BREAKING NEWS: FDA advisory committee recommends approval of a booster shot of the Johnson & Johnson COVID-19 vaccine in ALL adults aged 18 and older two months after the first dose

• The FDA’s advisory committee unanimously voted to recommend approval of Covid booster shots of Johnson & Johnson’s vaccine on Friday
• The booster shot will be available to all adults aged 18 and older and given two months after the first dose  

By Mary Kekatos U.S. Health Editor For Dailymail.Com

Published: 13:38 EDT, 15 October 2021 | Updated: 13:39 EDT, 15 October 2021

An advisory committee for the U.S. Food and Drug Administration (FDA) has unanimously voted to recommend approval of booster doses of Johnson & Johnson’s COVID-19 vaccine.

The boosters have been approved for all adults aged 18 and older and will be given two months after the first dose.  

It comes exactly one day after the Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended approval of boosters for the Moderna vaccine. 

The FDA’s advisory committee unanimously voted to recommend approval of Covid booster shots of Johnson & Johnson’s vaccine on Friday. Pictured: Johnson & Johnson COVID-19 vaccine at a pharmacy in Denver, October 2021

This is a breaking new story and will be updated.

Advertisement